| Dec'17 | Dec'16 | Dec'15 | ||||
|---|---|---|---|---|---|---|
Revenues | ||||||
25,188 | 44,808 | 55,864 | ||||
Other income | ||||||
8,528 | 11,637 | 6,701 | ||||
Total revenues and other income | ||||||
33,715 | 56,444 | 62,565 | ||||
Operating expenses | ||||||
Royalty expenses | ||||||
2,620 | 1,777 | 2,746 | ||||
Research and development expenses | ||||||
79,227 | 78,458 | 58,154 | ||||
Selling, general and administrative expenses | ||||||
44,750 | 43,413 | 30,223 | ||||
Other operating income and expenses | ||||||
232 | -99 | -2,425 | ||||
Total operating expenses | ||||||
126,366 | 123,746 | 93,549 | ||||
Operating income (loss) | ||||||
-92,650 | -67,302 | -30,984 | ||||
Financial income | ||||||
7,262 | 7,147 | 10,253 | ||||
Financial expenses | ||||||
18,294 | 7,101 | 1,876 | ||||
Financial gain (loss) | ||||||
-11,032 | 46 | 8,378 | ||||
Income tax | ||||||
0 | 0 | 0 | ||||
Net income (loss) | ||||||
-103,683 | -67,255 | -22,606 | ||||
Attributable to shareholders of Cellectis | ||||||
-99,368 | -67,255 | -22,796 | ||||
Attributable to non-controlling interests | ||||||
-4,315 | - | 190 | ||||
Basic / Diluted net income (loss) per share attributable to shareholders of Cellectis | ||||||
Basic net income (loss) per share ($ /share) | ||||||
-2.78 | -1.91 | -0.67 | ||||
Diluted net income (loss) per share ($ /share) | ||||||
-2.78 | -1.91 | -0.67 | ||||